Recifercept
Recifercept (TA-46) is a soluble, recombinant fibroblast growth factor receptor 3 (FGFR3) molecule. Recifercept can be used as a decoy/ligand trap to decrease the amount of fibroblast growth factors that can bind to mutant FGFR3 receptors. Recifercept can be used for the research of achondroplasia[1].
Product Specifications
CAS Number
[2226238-09-9]
Product Name Alternative
TA-46; sFGFR3
UNSPSC
12352203
Target
FGFR
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/recifercept.html
Purity
97.10
Solubility
H2O
Smiles
[Recifercept]
Molecular Weight
(37.72 kDa)
References & Citations
[1]Gonçalves D, et al. In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia. PLoS One. 2020 Dec 28;15 (12) :e0244368.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MF-0136521-01 5 µg
Influenza A H1N1 (A/Brisbane/02/2018) Hemagglutinin/HA Protein (His)
Ask
View Details 
MF-0136521-02 10 µg
Influenza A H1N1 (A/Brisbane/02/2018) Hemagglutinin/HA Protein (His)
Ask
View Details MF-0136521-03 20 µg
Influenza A H1N1 (A/Brisbane/02/2018) Hemagglutinin/HA Protein (His)
Ask
View Details 
MF-0136521-04 50 µg
Influenza A H1N1 (A/Brisbane/02/2018) Hemagglutinin/HA Protein (His)
Ask
View Details 
MF-0136521-05 100 µg
Influenza A H1N1 (A/Brisbane/02/2018) Hemagglutinin/HA Protein (His)
Ask
View Details MF-0136521-06 200 µg
Influenza A H1N1 (A/Brisbane/02/2018) Hemagglutinin/HA Protein (His)
Ask
View Details